The crisis at 23andMe, explained
Alex Graur
In This Story ME +2.75% GOOGL -0.07% 23andMe ( ME +2.75% ), the company that popularized consumer genetic testing, is facing significant financial and leadership challenges as it approaches the possibility of being delisted from the Nasdaq. Suggested Reading Rolls Royce, Lamborghini, and Tesla: Look inside Donald Trump’s garage Taco Bell, KFC, and Pizza Hut are pulling onions following E. coli outbreak Southwest Airlines plans to speed up its turnaround — literally McDonald’s is facing its
astăzi